All Stories

Cyclacel Pharmaceuticals sheds clinical cancer asset in effort to stop cash spiral

Struggling Cyclacel Pharmaceuticals is dropping one of its two clinical stage assets in an effort to save cash, the company’s new owners announced on Apr. 2.

Apr 3, 2025 - 08:43
 0
Cyclacel Pharmaceuticals sheds clinical cancer asset in effort to stop cash spiral
Struggling Cyclacel Pharmaceuticals is dropping one of its two clinical stage assets in an effort to save cash, the company’s new owners announced on Apr. 2.
Read More

Tags:

Previous Article

Lotus Robotics and Here Technologies collaborate on Highway Navigation Pilot for...

Next Article

Clinical Trials Information System designated as WHO primary registry

Related Posts

UK court rules against Abbott in diabetes CGM trademark case versus Sinocare

UK court rules against Abbott in diabetes CGM trademark...

Feb 12, 2025  0

Pyxis lays off 20% of staff to swing behind single-candidate strategy

Pyxis lays off 20% of staff to swing behind single-cand...

Mar 18, 2025  0

Volta Medical's afib AI shows gains in cardiac ablation study

Volta Medical's afib AI shows gains in cardiac ablation...

Feb 17, 2025  0